FineHeart receives Slovenia JAZMP authorizationto launch its FIH clinical study on patients sufferingfrom advanced heart failure
Bordeaux, France – Ljubljana, Slovenia, July 1rst 2025 - a clinical-stage medical technology company specializing in the development of innovative solutions for cardiology, announces that it has received authorization from JAZMP, the Agency for Medicinal Products and Medical Devices of the Republic of Slovenia, to begin its First-In-Human (FIH) clinical study.